quinazolines has been researched along with Absence Seizure Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Császár, I; Juhász, G; Kovács, Z; Nyitrai, G; Palkovits, M; Papp, E; Puskás, L | 1 |
| Fukuyama, Y; Seki, T | 1 |
2 other study(ies) available for quinazolines and Absence Seizure Disorder
| Article | Year |
|---|---|
Suppression of spike-wave discharge activity and c-fos expression by 2-methyl-4-oxo-3H-quinazoline-3-acetyl piperidine (Q5) in vivo.
Topics: Animals; Anticonvulsants; Brain Chemistry; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Absence; Gene Expression; Genes, fos; Immunohistochemistry; Nerve Net; Pain; Piperidines; Quinazolines; Rats; Rats, Inbred Strains; Stress, Psychological | 2007 |
[Clinical evaluation of 2-(beta-pyridyl-(2")-ethenyl)-3-(2'-methylphenyl)-quinazolinone-(4) (B169) in the treatment of epilepsy].
Topics: Adolescent; Child; Child, Preschool; Electroencephalography; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Ethylenes; Female; Humans; Infant; Intellectual Disability; Male; Movement Disorders; Pyridines; Quinazolines; Sleep | 1971 |